Trying to Conceive: Do Sildenafil or Tadalafil Affect Sperm and Fertility?

Helping an erection can improve the chance that intercourse happens during the fertile window. That is not the same as proving the medication improves sperm or pregnancy rates.

Researched by the EdClinic Editorial Team · our research standards · not a substitute for professional medical or legal advice

Separate four different fertility questions

A normal erection does not prove normal sperm, and an abnormal semen analysis does not necessarily mean pregnancy is impossible. AUA/ASRM guidance emphasizes reproductive history and one or more semen analyses for the male partner, with parallel evaluation of both partners.

What studies of sildenafil found

Small randomized studies in healthy men found that a single sildenafil dose did not significantly worsen sperm count, motility, density, morphology, vitality, ejaculate volume, or viscosity. Another crossover study similarly reported no change in seminal parameters and observed a shorter refractory period under continued stimulation.

Those findings are reassuring but narrow. The studies involved small groups, specific doses, acute exposure, and laboratory semen outcomes. In-vitro research has sometimes produced conflicting findings, including effects on motility or the acrosome reaction. A drug placed directly into a semen sample is not the same exposure as a prescribed tablet metabolized by the body, but the inconsistency is a reason not to advertise sildenafil as a fertility enhancer.

What longer tadalafil studies found

Randomized placebo-controlled studies evaluated daily tadalafil for six to nine months, including doses higher than the common 5 mg daily ED regimen. Investigators generally found no deleterious effect on sperm concentration, total count, motility, morphology, or reproductive hormones. In the nine-month study, more tadalafil participants experienced a 50% concentration reduction than placebo participants, yet the prespecified noninferiority criterion was met and secondary measures did not differ significantly.

That nuance matters. “No demonstrated overall harm in the study” is more accurate than “tadalafil can never affect anyone’s semen.” The participants were largely men aged 45 or older, and study design, dose, duration, baseline fertility, and individual variability limit what can be generalized.

Why compounded combination products are a different question

A compounded chew or troche may include sildenafil, tadalafil, apomorphine, oxytocin, PT-141, supplements, or other ingredients. Evidence about approved sildenafil or tadalafil tablets cannot automatically be assigned to the finished combination. The product is not FDA-approved, the dose may differ, and reproductive data on the combination may be absent.

Trying to conceive is a reason to demand the exact ingredient list and strength, not to accept “performance blend” as sufficient labeling. Also disclose testosterone or anabolic steroid use. Exogenous testosterone can suppress sperm production and is a far more direct fertility concern than many men realize.

When to move from reassurance to evaluation

ASRM defines infertility based on the clinical situation, but for couples having regular unprotected intercourse without known risk factors, evaluation is commonly initiated after 12 months when the female partner is under 35 and after six months when she is 35 or older. Evaluation should begin sooner when there is a known risk factor, sexual dysfunction preventing intercourse, testicular injury, chemotherapy, absent ejaculation, or suspected male subfertility.

• Bring a complete medication and supplement list.
• Report testosterone, finasteride, anabolic steroids, cannabis, and recreational drugs.
• Describe whether ED prevents intercourse during the fertile window.
• Obtain semen analysis rather than relying on appearance or volume.
• Evaluate both partners concurrently when appropriate.
• Repeat an abnormal semen analysis because parameters vary between samples.

When the medication solves a logistics problem, not a sperm problem

For some couples, the main barrier is that ED prevents intercourse during the fertile window. ASRM notes that intercourse every one to two days during the fertile window produces the highest pregnancy rates, with two to three times weekly nearly equivalent for many couples. A prescribed PDE5 inhibitor may make that schedule possible. The benefit is behavioral and mechanical: intercourse occurs. It does not establish that the medicine improved sperm biology.

This distinction matters when the couple has delayed conception. If sildenafil restores intercourse but pregnancy still does not occur, repeatedly changing the ED dose is not a fertility workup. Both partners should be evaluated on the appropriate timeline, and the male partner should provide a reproductive history and semen analysis. Sexual dysfunction itself can justify earlier assessment because the couple may not be achieving regular exposure during the fertile window.

Collection for semen analysis can create another problem. Some men can have intercourse with medication but struggle to produce a sample in a clinic. Tell the fertility center before the appointment. It may permit home collection under specific timing and transport rules or offer another protocol. Do not add sildenafil, lubricant, or a collection condom without instruction because products and timing can affect the sample.

Frequently asked questions

Does Viagra lower sperm count?

Small acute human studies did not show a significant harmful effect on standard semen measures, but individual fertility concerns require evaluation.

Does Cialis improve sperm?

Some studies report neutral or improved parameters, but tadalafil is not an approved male-fertility treatment and pregnancy benefit is not established.

Can ED medication harm a future baby through semen?

The amount of sildenafil measured in ejaculate after a dose was extremely small in one study, but discuss medication use with a fertility clinician when concerns exist.

Should I stop ED medication while trying to conceive?

Do not stop a prescription solely from internet advice. Discuss the indication, formula, dose, and fertility history with the prescriber.

How EdClinic researched this question

We treated the search phrase as a real decision rather than a prompt for a generic medication summary. The evidence hierarchy started with official prescribing information, federal health and consumer-protection guidance, professional urology or reproductive-medicine guidelines, and peer-reviewed clinical research. Commercial provider pages were used only when the article discusses what a buyer should verify before paying.

We also separated facts from variables. A drug label can describe dosing limits, warnings, and expected pharmacology, but it cannot determine why one reader had a specific experience. Federal privacy rules can describe rights, yet coverage may depend on which company holds the data and what role it plays. Travel and subscription rules can change by destination or state. Wherever the correct answer depends on those hidden details, the article gives the reader a specific question for the prescriber, pharmacist, insurer, provider, embassy, or regulator.

The practical standard is conservative: do not improvise a second dose, do not assume marketing language has legal meaning, and do not let embarrassment block a medical or privacy question that materially affects the decision.

Continue the investigation